Healthcare & Life Sciences
QurAlis
United Statesquralis.com
QurAlis is a series a startup based in United States. 2 investors tracked.
Activeseries-b
series-b
Stage
2018
Founded
2
Investors
About QurAlis
QurAlis is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
QurAlis is a clinical-stage biotechnology company developing precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. They focus on discovering and advancing targeted therapies to address the underlying causes of these conditions.
Explore QurAlis's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.